MarketPeel
Insider Trading Intelligence
Pricing
…
JP

Jonathan Poole

ACAD
DIRECTOR · ACADIA PHARMACEUTICALS INC · CIK 0001604689
FILING MIX · LIFETIME100%/0%
BUYS
4
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Mar 2026
HOLDINGS NOW
2,010
AVG SELL PX
—
TRADE KIND
SHOWING 4 / 4
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Jonathan Poole. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
ACAD · 2,010 shares · as of Mar 3, 2026
01,8713,7415,6127,482SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 4 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
4,218——4,218Mar 3, 2026Mar 20, 2026 ↗
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
3,565——3,565Mar 3, 2026Mar 20, 2026 ↗
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
7,482——7,482Mar 3, 2026Mar 20, 2026 ↗
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,010——2,010Mar 3, 2026Mar 20, 2026 ↗
Other insiders · ACAD
Loading peer insiders…
About this filer
CIK 0001604689
ROLE
Director
PRIMARY
ACAD
COMPANIES
1
ACTIVE SINCE
Mar 2026
MARKETPEEL · /INSIDER/0001604689DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback